Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 17/20 | 0.50 |
| ▸ | CNR2 | P34972 | 16/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2925424 | 0.89 | PLA2G2A (0.47) | CNR1CNR2 | |
| SCHEMBL2925326 | 0.82 | CNR1 (0.42) | CNR1CNR2HPGD | |
| SCHEMBL2927304 | 0.81 | CNR2 (0.39) | CNR1CNR2KMT2A | |
| SCHEMBL2921102 | 0.79 | PDE3B (0.41) | CNR1CNR2 | |
| SCHEMBL1744284 | 0.78 | LMNA (0.54) | — | |
| SCHEMBL2182906 | 0.77 | KMT2A (0.51) | KMT2A | |
| SCHEMBL2179684 | 0.77 | KMT2A (0.51) | KMT2A | |
| SCHEMBL2182231 | 0.77 | KMT2A (0.51) | KMT2A | |
| SCHEMBL13863177 | 0.77 | PLA2G2A (0.52) | CNR1CNR2MEN1HPGDKMT2A | |
| SCHEMBL22097373 | 0.77 | ITGB3 (0.43) | CNR1CNR2MEN1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1735358-B1 | A PROCESS FOR THE PREPARATION OF VINYLAROMATIC (CO)POLYMERS GRAFTED ON AN ELASTOMER IN A CONTROLLED WAY | VERSALIS SPA (IT) | 2018-10-24 | — | — | EP | disclosed |
| US-8722620-B2 | Insulin derivatives | NOVO NORDISK A/S (DK) | 2014-05-13 | — | — | US | disclosed |
| EP-2256129-A1 | Insulin derivatives | NOVO NORDISK A/S (DK) | 2010-12-01 | — | — | EP | disclosed |
| EP-1991576-B1 | INSULIN DERIVATIVES | NOVO NORDISK AS (DK) | 2010-09-29 | — | — | EP | disclosed |
| EP-1914283-B1 | Photo-catalytic coating for metal materials | GLOBAL ENGINEERING S R L (IT) | 2010-09-29 | — | — | EP | disclosed |
| US-20090137454-A1 | Insulin Derivatives | NOVO NORDISK A/S (DK) | 2009-05-28 | — | — | US | disclosed |
| EP-1991576-A1 | INSULIN DERIVATIVES | Novo Nordisk A/S (DK) | 2008-11-19 | — | — | EP | disclosed |
| EP-1914283-A1 | Photo-catalytic coating for metal materials | Global Engineering and Trade S.p.A. (IT) | 2008-04-23 | — | — | EP | disclosed |
| US-20070213469-A1 | A process for the preparation of vicylaromatiic (co) polymers grafted on an elastomer in a cotrolled way | POLIMERI EUROPA S.P.A. (IT) | 2007-09-13 | — | — | US | disclosed |
| WO-2007096431-A1 | INSULIN DERIVATIVES | NOVO NORDISK A/S (DK) | 2007-08-30 | — | — | WO | disclosed |
| EP-1735358-A1 | A PROCESS FOR THE PREPARATION OF VINYLAROMATIC (CO)POLYMERS GRAFTED ON AN ELASTOMER IN A CONTROLLED WAY | Polimeri Europa S.p.A. (IT) | 2006-12-27 | — | — | EP | disclosed |
| WO-2005100425-A1 | A PROCESS FOR THE PREPARATION OF VINYLAROMATIC (CO)POLYMERS GRAFTED ON AN ELASTOMER IN A CONTROLLED WAY | POLIMERI EUROPA S.P.A. (IT) | 2005-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137454-A1 | Insulin Derivatives | IAPP, INSR, GPR119 | CNR1 3956/4885CNR2 4031/4885MEN1 626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.